Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Form 13F · Q2 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd.

CIK 2032331Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$459M
Reported book value
129
Positions
7
Quarters on record
Top 50
Positions

Arrowpoint Investment Partners (Singapore) Pte. Ltd. — holdings

Top 50 positions of 129, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1C Citigroup Inc235,033—$33M7.2%
2GS Goldman Sachs Group Inc30,971—$31M6.8%
3GLOBAL PMTS INC Global Pmts Inc384,114—$28M6.1%
4NORFOLK SOUTHN CORP Norfolk Southn Corp81,332—$26M5.6%
5AMERICAN ELEC PWR CO INC American Elec Pwr Co Inc185,962—$25M5.5%
6NVDA Nvidia Corporation125,539—$25M5.5%
7EXXON MOBIL CORP Exxon Mobil Corp179,273—$25M5.3%
8GOOGL Alphabet Inc34,557+11.0%$12M2.7%
9MU Micron Technology Inc6,519—$8M1.6%
10INTC Intel Corp33,371—$5M1.0%
11SNDK Sandisk Corp2,008—$5M1.0%
12ARGX Argenx Se4,392—$4M0.9%
13INFY Infosys Ltd367,077—$4M0.8%
14CAT Caterpillar Inc3,539—$4M0.8%
15AXSM Axsome Therapeutics Inc.13,831−15.7%$3M0.7%
16INSM Insmed Inc30,170+329.9%$3M0.7%
17UNH Unitedhealth Group Inc7,657+46.8%$3M0.7%
18BRKR Bruker Corp52,780—$3M0.7%
19MDGL Madrigal Pharmaceuticals Inc5,865+392.0%$3M0.7%
20TVTX Travere Therapeutics Inc55,112—$3M0.7%
21HUM Humana Inc7,839—$3M0.7%
22LLY Eli Lilly & Co2,548+476.5%$3M0.7%
23RVTY Revvity Inc27,316—$3M0.7%
24PTCT Ptc Therapeutics Inc36,873−7.1%$3M0.7%
25ABBV Abbvie Inc11,928—$3M0.7%
26CHE Chemed Corp New6,365—$3M0.6%
27ISHARES TR Ishares Tr4,590—$3M0.6%
28A Agilent Technologies Inc21,826—$3M0.6%
29NBIX Neurocrine Biosciences Inc16,490−23.5%$3M0.6%
30TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd81,993+217.7%$3M0.6%
31ALAB Astera Labs Inc5,293—$3M0.6%
32COOPER COS INC Cooper Cos Inc34,743+489.3%$2M0.5%
33TWST Twist Bioscience Corp20,287+50.5%$2M0.5%
34QCOM Qualcomm Inc11,141—$2M0.4%
35ACHC Acadia Healthcare Company In66,843—$2M0.4%
36DVA Davita Inc8,046—$2M0.4%
37ALNY Alnylam Pharmaceuticals Inc5,588—$2M0.4%
38CON Concentra Group Holdings Par52,747—$2M0.3%
39BMRN Biomarin Pharmaceutical Inc27,041−44.5%$2M0.3%
40BIIB Biogen Inc6,838+45.3%$1M0.3%
41OSCR Oscar Health Inc51,105—$1M0.3%
42LRCX Lam Research Corp3,230—$1M0.3%
43SELECT SECTOR SPDR TR Select Sector Spdr Tr8,600—$1M0.3%
44AVTR Avantor Inc131,088—$1M0.3%
45RMBS Rambus Inc Del9,559—$1M0.3%
46ISHARES INC Ishares Inc11,100−11.2%$1M0.3%
47RVMD Revolution Medicines Inc6,100−23.5%$1M0.2%
48MRNA Moderna Inc14,841−13.2%$1M0.2%
49BBIO Bridgebio Pharma Inc13,454+132.6%$1M0.2%
50IONS Ionis Pharmaceuticals Inc12,338−68.4%$978,2800.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.